The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Simultaneous assessment of targeted anticancer therapy-associated mucocutaneous adverse events.
Christine Bettine Boers-Doets
No relevant relationships to disclose
Hans Gelderblom
No relevant relationships to disclose
Joel Brian Epstein
No relevant relationships to disclose
Mario E. Lacouture
No relevant relationships to disclose
Ad A Kaptein
No relevant relationships to disclose